PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91025C00050PHASE i - development of therapeutic — Nomocan Pharmaceuticals LLC

Nomocan Pharmaceuticals LLC holds $499K across 2 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 16 offers. Set-aside status: Small business. Recompete timing centers on the Sep 14, 2027 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci
Awarding office
Nomocan Pharmaceuticals LLC
Recipient
Sep 14, 2027
PoP end
$499K
Obligated
$499K
Potential
541715
NAICS
AN12
PSC
Small business
Set-aside
16 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Small business
Contract number75N91025C00050
AgencyNih Nci
Awarding officeNih Nci
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentNomocan Pharmaceuticals LLC
CAGE7ER28
UEIH9T8M7ZBYAR8
NAICS541715
PSCAN12
Place of performanceNEW YORK NY
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition After Exclusion Of Sources
Related solicitation75N91024R00019
PoP startSep 15, 2025
PoP end (current)Sep 14, 2027
Obligated$499K
Current value$499K
Potential value$499K

PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACTRIPTION. is a federal Small business award for Nih Nci held by Nomocan Pharmaceuticals LLC. Estimated value $499K ($499K obligated). Current period of performance ends Sep 14, 2027. Last award drew 16 bidders. Place of performance: NEW YORK NY. Related solicitation 75N91024R00019.

PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACTRIPTION.

Recompete timing

Public
● Expiring in 352 days

Current PoP ends Sep 14, 2027 (352 days remaining). Agencies typically plan 12–18 months ahead — at 11.6 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 75N91025C00050? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Nomocan Pharmaceuticals LLC — $499K obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$499K · 100% of firm total
Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N91025C00050?

75N91025C00050 (PHASE i - development of therapeutic) is a Nih Nci award with a potential value of $499K, currently held by Nomocan Pharmaceuticals LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91025C00050?

Nih Nci awarded 75N91025C00050 to Nomocan Pharmaceuticals LLC (potential $499K).

Who is the incumbent on 75N91025C00050?

Nomocan Pharmaceuticals LLC is the incumbent with $499K across 2 related awards in SCOUT’s public footprint. The current period of performance ends Sep 14, 2027.

When does Nomocan Pharmaceuticals LLC’s 75N91025C00050 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75N91025C00050? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91025C00050